As noted above, Levcromakalim, a Kir6.1/SUR2B channel opener, induces migraine headaches through the dilation of extracerebral arteries, suggesting that vascular KATP channel inhibitors might help treat migraines (Clement et al., 2023). Here, KCNJ8 is linked to Headache.